The immunometabolic function of VGLL3 and female-biased autoimmunity-Immunometabolism-CSCIED科技核心评价数据库-手机版

The immunometabolic function of VGLL3 and female-biased autoimmunity

The immunometabolic function of VGLL3 and female-biased autoimmunity

ES评分 0 浏览量：1048 下载量：0

DOI	10.1097/IN9.0000000000000041
刊名	Immunometabolism IJ
年，卷(期)	2024, 6(2)
作者	Kennicott, Kameron; Liang, Yun,
作者单位	[Kennicott, Kameron; Liang, Yun] Michigan State Univ, Dept Physiol, E Lansing, MI 48825 USA; [Kennicott, Kameron; Liang, Yun] Michigan State Univ, Dept Pharmacol & Toxicol, E Lansing, MI 48825 USA
摘要	Autoimmune diseases exhibit a pronounced yet unexplained prevalence among women. Vestigial-like family member 3 (VGLL3), a female-biased factor that promotes autoimmunity, has recently been discovered to assist cells in sensing and adapting to nutritional stress. This role of VGLL3 may confer a selective advantage during the evolution of placental mammals. However, the excessive activation of the VGLL3-mediated energy-sensing pathway can trigger inflammatory cell death and the exposure of self-antigens, leading to the onset of autoimmunity. These observations have raised the intriguing perspective that nutrient sensing serves as a double-edged sword in immune regulation. Mechanistically, VGLL3 intersects with Hippo signaling and activates multiple downstream, immune-associated genes that play roles in metabolic regulation. Understanding the multifaceted roles of VGLL3 in nutrient sensing and immune modulation provides insight into the fundamental question of sexual dimorphism in immunometabolism and sheds light on potential therapeutic targets for autoimmune diseases.
Abstract	Autoimmune diseases exhibit a pronounced yet unexplained prevalence among women. Vestigial-like family member 3 (VGLL3), a female-biased factor that promotes autoimmunity, has recently been discovered to assist cells in sensing and adapting to nutritional stress. This role of VGLL3 may confer a selective advantage during the evolution of placental mammals. However, the excessive activation of the VGLL3-mediated energy-sensing pathway can trigger inflammatory cell death and the exposure of self-antigens, leading to the onset of autoimmunity. These observations have raised the intriguing perspective that nutrient sensing serves as a double-edged sword in immune regulation. Mechanistically, VGLL3 intersects with Hippo signaling and activates multiple downstream, immune-associated genes that play roles in metabolic regulation. Understanding the multifaceted roles of VGLL3 in nutrient sensing and immune modulation provides insight into the fundamental question of sexual dimorphism in immunometabolism and sheds light on potential therapeutic targets for autoimmune diseases.
关键词	autoimmunity; immunometabolism; nutrient sensing; sexual dimorphism
KeyWord	autoimmunity; immunometabolism; nutrient sensing; sexual dimorphism
基金项目
页码	1-5

参考文献
相关文献

[1]. American Autoimmune Related Diseases Association. The Cost Burden of Autoimmune Diseases: The Latest Front in the War on Healthcare Spending. Eastpointe (MI, US). American Autoimmune Related Diseases Association; 2011.

[2]. Collison J. Autoimmunity: the ABCs of autoimmune disease. Nat Rev Rheumatol. 2018;14(5):248.

[3]. Liang Y, Tsoi LC, Xing X, et al. A gene network regulated by the transcription factor VGLL3 as a promoter of sex-biased autoimmune diseases. Nat Immunol. 2017;18(2):152-60.

[4]. Manuel RSJ, Liang Y. Sexual dimorphism in immunometabolism and autoimmunity: impact on personalized medicine. Autoimmun Rev. 2021;20(4):102775.

[5]. Pagenkopf A, Liang Y. Immunometabolic function of the transcription cofactor VGLL3 provides an evolutionary rationale for sexual dimorphism in autoimmunity. FEBS Lett. 2020;594(20):3371-83.

[6]. Billi AC, Gharaee-Kermani M, Fullmer J, et al. The female-biased factor VGLL3 drives cutaneous and systemic autoimmunity. JCI Insight. 2019;4(8):e127291.

[7]. Pucino V, Guma M. Editorial: the role of immunometabolism in autoimmune mediated and autoinflammatory disorders. Front Immunol. 2022;13:969939.

[8]. O’Neill LA, Kishton RJ, Rathmell J. A guide to immunometabolism for immunologists. Nat Rev Immunol. 2016;16(9):553-65.

[9]. Xu J, Chen C, Yin J, et al. Lactate-induced mtDNA accumulation activates cGAS-STING signaling and the inflammatory response in Sjogren’s syndrome. Int J Med Sci. 2023;20(10):1256-71.

[10]. Li W, Sivakumar R, Titov AA, et al. Metabolic factors that contribute to lupus pathogenesis. Crit Rev Immunol. 2016;36(1):75-98.

[11]. Efeyan A, Comb WC, Sabatini DM. Nutrient-sensing mechanisms and pathways. Nature. 2015;517(7534):302-10.

[12]. Della Torre S, Benedusi V, Fontana R, et al. Energy metabolism and fertility: a balance preserved for female health. Nat Rev Endocrinol. 2014;10(1):13-23.

[13]. Vousden KH, Ryan KM. p53 and metabolism. Nat Rev Cancer. 2009;9(10):691-700.

[14]. Ramirez-Carrozzi V, Sambandam A, Luis E, et al. IL-17C regulates the innate immune function of epithelial cells in an autocrine manner. Nat Immunol. 2011;12(12):1159-66.

[15]. Mistry P, Kaplan MJ. Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin Immunol. 2017;185:59-73.

[16]. Wu H, Zeng L, Ou J, et al. Estrogen acts through estrogen receptor-beta to promote mannan-induced psoriasis-like skin inflammation. Front Immunol. 2022;13:818173.

[17]. Kovacs T, Szabo-Meleg E, Abraham IM. Estradiol-induced epigenetically mediated mechanisms and regulation of gene expression. Int J Mol Sci. 2020;21(9):3177.

[18]. Eaton SA, Sethi JK. Immunometabolic links between estrogen, adipose tissue and female reproductive metabolism. Biology (Basel). 2019;8(1):8.

[19]. Cody NA, Shen Z, Ripeau JS, et al. Characterization of the 3p12.3-pcen region associated with tumor suppression in a novel ovarian cancer cell line model genetically modified by chromosome 3 fragment transfer. Mol Carcinog. 2009;48(12):1077-92.

[20]. Lian X, Yang K, Li R, et al. Immunometabolic rewiring in tumorigenesis and anti-tumor immunotherapy. Mol Cancer. 2022;21(1):27.

[21]. Ma S, Tang T, Probst G, et al. Transcriptional repression of estrogen receptor alpha by YAP reveals the Hippo pathway as therapeutic target for ER(+) breast cancer. Nat Commun. 2022;13(1):1061.

[22]. Liu Y, Chen S, Zhang E, et al. Exploring the potential of VGLL3 methylation as a prognostic indicator for intracranial aneurysm with gender-specific considerations. Biosci Rep. 2024;44(3):BSR20231374.

[23]. Simon E, Faucheux C, Zider A, et al. From vestigial to vestigial-like: the Drosophila gene that has taken wing. Dev Genes Evol. 2016;226(4):297-315.

[24]. Fu M, Hu Y, Lan T, et al. The Hippo signalling pathway and its implications in human health and diseases. Signal Transduct Target Ther. 2022;7(1):376.

[25]. Yan L, Cai Q, Xu Y. Hypoxic conditions differentially regulate TAZ and YAP in cancer cells. Arch Biochem Biophys. 2014;562:31-6.

[26]. Luo M, Meng Z, Moroishi T, et al. Heat stress activates YAP/TAZ to induce the heat shock transcriptome. Nat Cell Biol. 2020;22(12):1447-59.

[27]. Hong AW, Meng Z, Plouffe SW, et al. Critical roles of phosphoinositides and NF2 in Hippo pathway regulation. Genes Dev. 2020;34(7-8):511-25.

[28]. Mo JS, Meng Z, Kim YC, et al. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol. 2015;17(4):500-10.

[29]. Wang W, Xiao ZD, Li X, et al. AMPK modulates Hippo pathway activity to regulate energy homeostasis. Nat Cell Biol. 2015;17(4):490-9.

[30]. Hori N, Okada K, Takakura Y, et al. Vestigial-like family member 3 (VGLL3), a cofactor for TEAD transcription factors, promotes cancer cell proliferation by activating the Hippo pathway. J Biol Chem. 2020;295(26):8798-807.

[31]. Kawamura T, Takehora Y, Hori N, et al. VGLL3 increases the dependency of cancer cells on de novo nucleotide synthesis through GART expression. J Cell Biochem. 2022;123(6):1064-76.

[32]. Zhang L, Li L, Mao Y, et al. VGLL3 is a prognostic biomarker and correlated with clinical pathologic features and immune infiltrates in stomach adenocarcinoma. Sci Rep. 2020;10(1):1355.

[33]. Clocchiatti A, Cora E, Zhang Y, et al. Sexual dimorphism in cancer. Nat Rev Cancer. 2016;16(5):330-9.

[34]. Bottini A, Wu DJ, Ai R, et al. PTPN14 phosphatase and YAP promote TGFbeta signalling in rheumatoid synoviocytes. Ann Rheum Dis. 2019;78(5):600-9.

[35]. Zhou W, Shen Q, Wang H, et al. Knockdown of YAP/TAZ inhibits the migration and invasion of fibroblast synovial cells in rheumatoid arthritis by regulating autophagy. J Immunol Res. 2020;2020:9510594.

[36]. Ueda Y, Kondo N, Kinashi T. MST1/2 balance immune activation and tolerance by orchestrating adhesion, transcription, and organelle dynamics in lymphocytes. Front Immunol. 2020;11:733.

[37]. Du Y, Cui R, Tian N, et al. Regulation of type I interferon signature by VGLL3 in the fibroblast-like synoviocytes of rheumatoid arthritis patients via targeting the Hippo pathway. Arthritis Res Ther. 2022;24(1):188.

[38]. Uppala R, Sarkar MK, Young KZ, et al. HERC6 regulates STING activity in a sex-biased manner through modulation of LATS2/VGLL3 Hippo signaling. iScience. 2024;27(2):108986.

[39]. Zhang J, Wong CC, Leung KT, et al. FGF18-FGFR2 signaling triggers the activation of c-Jun-YAP1 axis to promote carcinogenesis in a subgroup of gastric cancer patients and indicates translational potential. Oncogene. 2020;39(43):6647-63.

[40]. Ahi EP, Sinclair-Waters M, Donner I, et al. A pituitary gene network linking vgll3 to regulators of sexual maturation in male Atlantic salmon. Comp Biochem Physiol A Mol Integr Physiol. 2023;275:111337.

[41]. Lukey MJ, Greene KS, Erickson JW, et al. The oncogenic transcription factor c-Jun regulates glutaminase expression and sensitizes cells to glutaminase-targeted therapy. Nat Commun. 2016;7:11321.

[42]. Serna R, Ramrakhiani A, Hernandez JC, et al. c-JUN inhibits mTORC2 and glucose uptake to promote self-renewal and obesity. iScience. 2022;25(6):104325.

[43]. Papavassiliou AG, Musti AM. The multifaceted output of c-jun biological activity: focus at the junction of CD8 T cell activation and exhaustion. Cells. 2020;9(11):2470.

[44]. Xu D, Lu W. Defensins: a double-edged sword in host immunity. Front Immunol. 2020;11:764.

[45]. Mburu YK, Abe K, Ferris LK, et al. Human beta-defensin 3 promotes NF-kappaB-mediated CCR7 expression and anti-apoptotic signals in squamous cell carcinoma of the head and neck. Carcinogenesis. 2011;32(2):168-74.

[46]. Capece D, Verzella D, Flati I, et al. NF-kappaB: blending metabolism, immunity, and inflammation. Trends Immunol. 2022;43(9):757-75.

[47]. Schneider P, MacKay F, Steiner V, et al. BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth. J Exp Med. 1999;189(11):1747-56.

[48]. Mackay F, Browning JL. BAFF: a fundamental survival factor for B cells. Nat Rev Immunol. 2002;2(7):465-75.

[49]. Kalled SL. The role of BAFF in immune function and implications for autoimmunity. Immunol Rev. 2005;204:43-54.

[50]. Giordano D, Kuley R, Draves KE, et al. B cell-activating factor (BAFF) from dendritic cells, monocytes and neutrophils is required for B cell maturation and autoantibody production in SLE-like autoimmune disease. Front Immunol. 2023;14:1050528.

[51]. Mackay F, Woodcock SA, Lawton P, et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med. 1999;190(11):1697-710.

[52]. McAllister E, Jellusova J. BAFF signaling in B cell metabolism. Curr Opin Immunol. 2021;71:69-74.

[53]. Banchereau J, Pascual V. Type I interferon in systemic lupus erythematosus and other autoimmune diseases. Immunity. 2006;25(3):383-92.

[54]. Wu D, Sanin DE, Everts B, et al. Type 1 interferons induce changes in core metabolism that are critical for immune function. Immunity. 2016;44(6):1325-36.

[55]. Olson GS, Murray TA, Jahn AN, et al. Type I interferon decreases macrophage energy metabolism during mycobacterial infection. Cell Rep. 2021;35(9):109195.

[56]. Raniga K, Liang C. Interferons: reprogramming the metabolic network against viral infection. Viruses. 2018;10(1):36.

[57]. Malik A, Kanneganti TD. Function and regulation of IL-1alpha in inflammatory diseases and cancer. Immunol Rev. 2018;281(1):124-37.

[58]. Cohen I, Rider P, Carmi Y, et al. Differential release of chromatin-bound IL-1alpha discriminates between necrotic and apoptotic cell death by the ability to induce sterile inflammation. Proc Natl Acad Sci U S A. 2010;107(6):2574-9.

[59]. Takakura Y, Hori N, Terada N, et al. VGLL3 activates inflammatory responses by inducing interleukin-1ɑ secretion. FASEB J. 2021;35(11):e21996.

[60]. Lynch EA, Dinarello CA, Cannon JG. Gender differences in IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist secretion from mononuclear cells and urinary excretion. J Immunol. 1994;153(1):300-6.

[61]. Matsuki T, Horai R, Sudo K, et al. IL-1 plays an important role in lipid metabolism by regulating insulin levels under physiological conditions. J Exp Med. 2003;198(6):877-88.

[62]. Zhou H, Wang H, Yu M, et al. IL-1 induces mitochondrial translocation of IRAK2 to suppress oxidative metabolism in adipocytes. Nat Immunol. 2020;21(10):1219-31.

[63]. Versini M, Jeandel PY, Rosenthal E, et al. Obesity in autoimmune diseases: not a passive bystander. Autoimmun Rev. 2014;13(9):981-1000.

引用本文

Kennicott, Kameron; Liang, Yun. The immunometabolic function of VGLL3 and female-biased autoimmunity [J]. Immunometabolism. 2024; 6; (2). 1 - 5.

文献评论

相关学者

相关机构